Augmentation of 2-arachidonoylglycerol signaling in astrocytes maintains synaptic functionality by regulation of miRNA-30b
Authors:
- 5 December 2022
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 361, 114292
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01AG058621, R01MH113535, R01NS076815)
This publication has 75 references indexed in Scilit:
- SIRT1 and SIRT2: emerging targets in neurodegenerationEMBO Molecular Medicine, 2013
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's DiseaseCell Reports, 2012
- MicroRNAs in neuronal function and dysfunctionTrends in Neurosciences, 2012
- Looking forward to EphB signaling in synapsesSeminars in Cell & Developmental Biology, 2012
- The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerationsThe Lancet Neurology, 2011
- Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insultsNeuroscience, 2011
- Dysregulated microRNAs in neurodegenerative disordersSeminars in Cell & Developmental Biology, 2010
- Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid MetabolismChemistry & Biology, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007